{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:07:40Z","timestamp":1779782860643,"version":"3.53.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11060-026-05576-6","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:05:24Z","timestamp":1777025124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term safety and efficacy of staged stereotactic radiosurgery with Ommaya reservoir aspiration for large cystic brain metastases"],"prefix":"10.1007","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7426-7654","authenticated-orcid":false,"given":"Shoji","family":"Yomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Yako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kitazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyota","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"5576_CR1","doi-asserted-by":"publisher","first-page":"74006","DOI":"10.18632\/oncotarget.12176","volume":"7","author":"B Sun","year":"2016","unstructured":"Sun B, Huang Z, Wu S, Ding L, Shen G, Cha L, Wang J, Song S (2016) Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer. Oncotarget 7:74006\u201374014. https:\/\/doi.org\/10.18632\/oncotarget.12176","journal-title":"Oncotarget"},{"key":"5576_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11060-019-03106-1","volume":"142","author":"RH Brigell","year":"2019","unstructured":"Brigell RH, Cagney DN, Martin AM, Besse LA, Catalano PJ, Lee EQ, Wen PY, Brown PD, Phillips JG, Pashtan IM, Tanguturi SK, Haas-Kogan DA, Alexander BM, Aizer AA (2019) Local control after brain-directed radiation in patients with cystic versus solid brain metastases. J Neurooncol 142:355\u2013363. https:\/\/doi.org\/10.1007\/s11060-019-03106-1","journal-title":"J Neurooncol"},{"key":"5576_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.25259\/SNI_291_2020","volume":"11","author":"AJ Kobets","year":"2020","unstructured":"Kobets AJ, Backus R, Fluss R, Lee A, Lasala PA (2020) Evaluating the natural growth rate of metastatic cancer to the brain. Surg Neurol Int 11:254. https:\/\/doi.org\/10.25259\/SNI_291_2020","journal-title":"Surg Neurol Int"},{"key":"5576_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3171\/jns\/2008\/109\/8\/0259","volume":"109","author":"A Franzin","year":"2008","unstructured":"Franzin A, Vimercati A, Picozzi P, Serra C, Snider S, Gioia L, Ferrari da Passano C, Bolognesi A, Giovanelli M (2008) Stereotactic drainage and Gamma Knife radiosurgery of cystic brain metastasis. J Neurosurg 109:259\u2013267. https:\/\/doi.org\/10.3171\/jns\/2008\/109\/8\/0259","journal-title":"J Neurosurg"},{"key":"5576_CR5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijrobp.2012.06.043","volume":"85","author":"JO Ebinu","year":"2013","unstructured":"Ebinu JO, Lwu S, Monsalves E, Arayee M, Chung C, Laperriere NJ, Kulkarni AV, Goetz P, Zadeh G (2013) Gamma knife radiosurgery for the treatment of cystic cerebral metastases. Int J Radiat Oncol Biol Phys 85:667\u2013671. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.06.043","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5576_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3892\/ol.2016.4603","volume":"12","author":"H Wang","year":"2016","unstructured":"Wang H, Qi S, Dou C, Ju H, He Z, Ma Q (2016) Gamma Knife radiosurgery combined with stereotactic aspiration as an effective treatment method for large cystic brain metastases. Oncol Lett 12:343\u2013347. https:\/\/doi.org\/10.3892\/ol.2016.4603","journal-title":"Oncol Lett"},{"key":"5576_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00701-020-04273-1","volume":"163","author":"ZHA Sadik","year":"2021","unstructured":"Sadik ZHA, Hanssens PEJ, Verheul JB, Ardon H, Lie ST, van der Pol B, Beute GN, Fleischeuer REM, Leenstra S (2021) Stereotactic cyst aspiration directly followed by Gamma Knife radiosurgery for large cystic brain metastases. Acta Neurochir (Wien) 163:343\u2013350. https:\/\/doi.org\/10.1007\/s00701-020-04273-1","journal-title":"Acta Neurochir (Wien)"},{"key":"5576_CR8","doi-asserted-by":"publisher","first-page":"okab028","DOI":"10.1093\/neuopn\/okab028","volume":"2","author":"DJM Park","year":"2021","unstructured":"Park DJM, PhD, Unadkat PM, Goenka AM, Schulder MM (2021) Case Series: Cystic Brain Metastases Managed With Reservoir Placement and Stereotactic Radiosurgery. Neurosurg Pract 2:okab028. https:\/\/doi.org\/10.1093\/neuopn\/okab028","journal-title":"Neurosurg Pract"},{"key":"5576_CR9","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3171\/2019.7.JNS191193","volume":"133","author":"S Yomo","year":"2020","unstructured":"Yomo S, Oda K, Oguchi K (2020) Single- versus 2-session Gamma Knife surgery for symptomatic midsize brain metastases: a propensity score-matched analysis. J Neurosurg 133:1646\u20131654. https:\/\/doi.org\/10.3171\/2019.7.JNS191193","journal-title":"J Neurosurg"},{"key":"5576_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3171\/2021.9.JNS211797","volume":"137","author":"S Yomo","year":"2022","unstructured":"Yomo S, Yako T, Kitazawa K, Oguchi K (2022) Staged radiosurgery alone versus postoperative cavity radiosurgery for patients with midsize-to-large brain metastases: a propensity score matching analysis. J Neurosurg 137:555\u2013562. https:\/\/doi.org\/10.3171\/2021.9.JNS211797","journal-title":"J Neurosurg"},{"key":"5576_CR11","doi-asserted-by":"publisher","unstructured":"Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY Response Assessment in Neuro-Oncology g (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16: e270\u2013278 https:\/\/doi.org\/10.1016\/S1470-2045(15)70057-4","DOI":"10.1016\/S1470-2045(15)70057-4"},{"key":"5576_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1227\/01.NEU.0000360391.35749.A5","volume":"66","author":"H Kano","year":"2010","unstructured":"Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD (2010) T1\/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 66:486\u2013491 discussion 491\u2009\u2013\u2009482. https:\/\/doi.org\/10.1227\/01.NEU.0000360391.35749.A5","journal-title":"Neurosurgery"},{"key":"5576_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1186\/s12885-017-3702-x","volume":"17","author":"S Yomo","year":"2017","unstructured":"Yomo S, Oguchi K (2017) Prospective study of (11)C-methionine PET for distinguishing between recurrent brain metastases and radiation necrosis: limitations of diagnostic accuracy and long-term results of salvage treatment. BMC Cancer 17:713. https:\/\/doi.org\/10.1186\/s12885-017-3702-x","journal-title":"BMC Cancer"},{"key":"5576_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.wneu.2023.10.131","volume":"182","author":"R Dharnipragada","year":"2024","unstructured":"Dharnipragada R, Dusenbery K, Ferreira C, Sharma M, Chen CC (2024) Preoperative Versus Postoperative Radiosurgery of Brain Metastases: A Meta-Analysis. World Neurosurg 182:35\u201341. https:\/\/doi.org\/10.1016\/j.wneu.2023.10.131","journal-title":"World Neurosurg"},{"key":"5576_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10143-024-03166-6","volume":"48","author":"SF Maroufi","year":"2025","unstructured":"Maroufi SF, Fallahi MS, Maroufi SP, Kassaeyan V, Palmisciano P, Sheehan JP (2025) Preoperative versus postoperative stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis of comparative studies. Neurosurg Rev 48:16. https:\/\/doi.org\/10.1007\/s10143-024-03166-6","journal-title":"Neurosurg Rev"},{"key":"5576_CR16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/neuros\/nyy436","volume":"85","author":"RH Press","year":"2019","unstructured":"Press RH, Zhang C, Chowdhary M, Prabhu RS, Ferris MJ, Xu KM, Olson JJ, Eaton BR, Shu HG, Curran WJ, Crocker IR, Patel KR (2019) Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery. Neurosurgery 85:632\u2013641. https:\/\/doi.org\/10.1093\/neuros\/nyy436","journal-title":"Neurosurgery"},{"key":"5576_CR17","doi-asserted-by":"publisher","first-page":"100644","DOI":"10.1016\/j.adro.2021.100644","volume":"6","author":"RS Prabhu","year":"2021","unstructured":"Prabhu RS, Turner BE, Asher AL, Marcrom SR, Fiveash JB, Foreman PM, Press RH, Buchwald ZS, Curran WJ Jr., Patel KR, Breen WG, Brown PD, Jethwa KR, Grills IS, Arden JD, Foster LM, Manning MA, Vaslow ZK, Burri SH, Soltys SG (2021) Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis. Adv Radiat Oncol 6:100644. https:\/\/doi.org\/10.1016\/j.adro.2021.100644","journal-title":"Adv Radiat Oncol"},{"key":"5576_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/neuonc\/noz049","volume":"21","author":"RS Prabhu","year":"2019","unstructured":"Prabhu RS, Turner BE, Asher AL, Marcrom SR, Fiveash JB, Foreman PM, Press RH, Patel KR, Curran WJ, Breen WG, Brown PD, Jethwa KR, Grills IS, Arden JD, Foster LM, Manning MA, Stern JD, Soltys SG, Burri SH (2019) A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases. Neuro Oncol 21:1049\u20131059. https:\/\/doi.org\/10.1093\/neuonc\/noz049","journal-title":"Neuro Oncol"},{"key":"5576_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaf182","author":"RA El Shafie","year":"2025","unstructured":"El Shafie RA, Bernhardt D, Welzel T, Schiele A, Schmitt D, Thalmann P, Erdem S, Eichkorn T, Paul A, Lang K, Konig L, Weykamp F, Adeberg S, Lentz-Hommertgen A, Jakel C, Bozorgmehr F, Thomas M, Sander A, Kieser M, Debus J, Rieken S (2025) Hypofractionated Stereotactic Radiotherapy versus Whole-Brain Radiotherapy following Brain Metastasis Resection - Results of the ESTRON Randomized Phase 2 Trial. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noaf182","journal-title":"Neuro Oncol"},{"key":"5576_CR20","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037\u20131044. https:\/\/doi.org\/10.1016\/S1470-2045(09)70263-3","journal-title":"Lancet Oncol"},{"key":"5576_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"R Soffietti","year":"2013","unstructured":"Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65\u201372. https:\/\/doi.org\/10.1200\/JCO.2011.41.0639","journal-title":"J Clin Oncol"},{"key":"5576_CR22","doi-asserted-by":"publisher","unstructured":"Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG 2nd, Deming R, Burri SH, Menard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL (2016) Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA 316:401\u2013409. https:\/\/doi.org\/10.1001\/jama.2016.9839","DOI":"10.1001\/jama.2016.9839"},{"key":"5576_CR23","doi-asserted-by":"publisher","unstructured":"Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1049\u20131060. https:\/\/doi.org\/10.1016\/S1470-2045(17)30441-2","DOI":"10.1016\/S1470-2045(17)30441-2"},{"key":"5576_CR24","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2147\/cmar.S188674","volume":"11","author":"H Wang","year":"2019","unstructured":"Wang H, Liu X, Jiang X, Song Y, Wang X, Wang J, Dong Y, Li F, Wu Z, Zhang Y, Yuan Z (2019) Cystic brain metastases had slower speed of tumor shrinkage but similar prognosis compared with solid tumors that underwent radiosurgery treatment. Cancer Manag Res 11:1753\u20131763. https:\/\/doi.org\/10.2147\/cmar.S188674","journal-title":"Cancer Manag Res"},{"key":"5576_CR25","doi-asserted-by":"publisher","first-page":"101304","DOI":"10.1016\/j.adro.2023.101304","volume":"9","author":"RF Amidon","year":"2024","unstructured":"Amidon RF, Livingston K, Kleefisch CJ, Martens M, Straza M, Puckett L, Schultz CJ, Mueller WM, Connelly JM, Noid G, Morris K, Bovi JA (2024) Cystic Brain Metastasis Outcomes After Gamma Knife Radiation Therapy. Adv Radiat Oncol 9:101304. https:\/\/doi.org\/10.1016\/j.adro.2023.101304","journal-title":"Adv Radiat Oncol"},{"key":"5576_CR26","doi-asserted-by":"publisher","first-page":"107327482412664","DOI":"10.1177\/10732748241266476","volume":"31","author":"L Sun","year":"2024","unstructured":"Sun L, Lin S, Bi J, Yuan Z, Li Y, Wei W, Peng Y, Hu D, Han G (2024) Evaluation of Radiotherapy Efficacy and Prognostic Analysis for Solid and Cystic Brain Metastases. Cancer Control 31:10732748241266476. https:\/\/doi.org\/10.1177\/10732748241266476","journal-title":"Cancer Control"},{"key":"5576_CR27","doi-asserted-by":"publisher","first-page":"104184","DOI":"10.1016\/j.bas.2025.104184","volume":"5","author":"DR Peters","year":"2025","unstructured":"Peters DR, Conti A, Levivier M, Schiappacasse L, Faouzi M, Trandafirescu MF, Tuleasca C (2025) Stereotactic aspiration alone or Ommaya placement and aspiration followed by stereotactic radiosurgery for cystic brain metastasis: A systematic review and meta-analysis. Brain Spine 5:104184. https:\/\/doi.org\/10.1016\/j.bas.2025.104184","journal-title":"Brain Spine"},{"key":"5576_CR28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.3118","author":"T Reungwetwattana","year":"2018","unstructured":"Reungwetwattana T, Nakagawa K, Cho BC, Cobo M, Cho EK, Bertolini A, Bohnet S, Zhou C, Lee KH, Nogami N, Okamoto I, Leighl N, Hodge R, McKeown A, Brown AP, Rukazenkov Y, Ramalingam SS, Vansteenkiste J (2018) CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer. J Clin Oncol: JCO2018783118. https:\/\/doi.org\/10.1200\/JCO.2018.78.3118","journal-title":"J Clin Oncol: JCO2018783118"},{"key":"5576_CR29","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa1805453","volume":"379","author":"HA Tawbi","year":"2018","unstructured":"Tawbi HA, Forsyth PA, Algazi A, Hamid O, Hodi FS, Moschos SJ, Khushalani NI, Lewis K, Lao CD, Postow MA, Atkins MB, Ernstoff MS, Reardon DA, Puzanov I, Kudchadkar RR, Thomas RP, Tarhini A, Pavlick AC, Jiang J, Avila A, Demelo S, Margolin K (2018) Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain. N Engl J Med 379:722\u2013730. https:\/\/doi.org\/10.1056\/NEJMoa1805453","journal-title":"N Engl J Med"},{"key":"5576_CR30","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1200\/JCO.19.00457","volume":"38","author":"JCH Yang","year":"2020","unstructured":"Yang JCH, Kim SW, Kim DW, Lee JS, Cho BC, Ahn JS, Lee DH, Kim TM, Goldman JW, Natale RB, Brown AP, Collins B, Chmielecki J, Vishwanathan K, Mendoza-Naranjo A, Ahn MJ (2020) Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study. J Clin Oncol 38:538\u2013547. https:\/\/doi.org\/10.1200\/JCO.19.00457","journal-title":"J Clin Oncol"},{"key":"5576_CR31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1470-2045(20)30111-X","volume":"21","author":"SB Goldberg","year":"2020","unstructured":"Goldberg SB, Schalper KA, Gettinger SN, Mahajan A, Herbst RS, Chiang AC, Lilenbaum R, Wilson FH, Omay SB, Yu JB, Jilaveanu L, Tran T, Pavlik K, Rowen E, Gerrish H, Komlo A, Gupta R, Wyatt H, Ribeiro M, Kluger Y, Zhou G, Wei W, Chiang VL, Kluger HM (2020) Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial. Lancet Oncol 21:655\u2013663. https:\/\/doi.org\/10.1016\/S1470-2045(20)30111-X","journal-title":"Lancet Oncol"},{"key":"5576_CR32","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/neuonc\/noae123","volume":"26","author":"R Bartsch","year":"2024","unstructured":"Bartsch R, Berghoff AS, Furtner J, Marhold M, Bergen ES, Roider-Schur S, Mair MJ, Starzer AM, Forstner H, Rottenmanner B, Aretin MB, Dieckmann K, Bago-Horvath Z, Haslacher H, Widhalm G, Ilhan-Mutlu A, Minichsdorfer C, Fuereder T, Szekeres T, Oehler L, Gruenberger B, Pfeiler G, Singer C, Weltermann A, Berchtold L, Preusser M (2024) Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases. Neuro Oncol 26:2305\u20132315. https:\/\/doi.org\/10.1093\/neuonc\/noae123","journal-title":"Neuro Oncol"},{"key":"5576_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3171\/jns.1997.87.2.0327","volume":"87","author":"B Karlsson","year":"1997","unstructured":"Karlsson B, Ericson K, Kihlstrom L, Grane P (1997) Tumor seeding following stereotactic biopsy of brain metastases. Report of two cases. J Neurosurg 87:327\u2013330. https:\/\/doi.org\/10.3171\/jns.1997.87.2.0327","journal-title":"J Neurosurg"},{"key":"5576_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jocn.2016.12.042","volume":"39","author":"A Oshima","year":"2017","unstructured":"Oshima A, Kimura T, Akabane A, Kawai K (2017) Optimal implantation of Ommaya reservoirs for cystic metastatic brain tumors preceding Gamma Knife radiosurgery. J Clin Neurosci 39:199\u2013202. https:\/\/doi.org\/10.1016\/j.jocn.2016.12.042","journal-title":"J Clin Neurosci"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05576-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05576-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05576-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:59:30Z","timestamp":1779782370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05576-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5576"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05576-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}